MIST — Milestone Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $80.70m
- $51.06m
- $1.55m
Brief: Milestone Pharmaceuticals Says NMPA Approval Triggers $2 Mln Milestone Payment To The Co
Milestone Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Canada's Milestone Pharma misses Q2 product revenue expectations
Milestone Pharmaceuticals Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Milestone Pharmaceuticals Inc - May Offer Securities Up To $300 Million - SEC Filing
Canada's Milestone Pharmaceuticals Q1 revenue misses estimates after CARDAMYST launch
Brief: Milestone Pharmaceuticals Appoints David Sandoval As General Counsel And Chief Compliance Officer
U.S. STOCKS ON THE MOVE-Brystol Myers, Nvidia
U.S. STOCKS ON THE MOVE-Vanda Pharma, Tesla, Zillow
U.S. STOCKS ON THE MOVE-Micron Technology, Carvana, ServiceNow
NASDAQ RESUMED AT 09:00 AM
Milestone Pharma gains on FDA approval of nasal spray for patients with heart condition
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
NASDAQ TRADE HALT HALT NEWS PENDING AT 06:06 PM
NASDAQ RESUMED AT 11:46 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:41 AM